Wipfli Financial Advisors Llc, Bluebird Bio, Inc. Transaction History
Wipfli Financial Advisors Llc,
- $1.42 Billion
- Q3 2022
A detailed history of Wipfli Financial Advisors Llc, transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Wipfli Financial Advisors Llc, holds 554 shares of BLUE stock, worth $4,016. This represents 0.0% of its overall portfolio holdings.
Number of Shares
554Holding current value
$4,016% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BLUE
# of Institutions
67Shares Held
39.7MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$112 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$33.8 Million0.02% of portfolio
-
Avidity Partners Management LP Dallas, TX1.63MShares$11.8 Million0.05% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.61MShares$11.7 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA975KShares$7.07 Million0.03% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $559M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...